On the 2nd of December 2004 in the "Radisson SAS Grand Hotel Sofia"  Association of Bulgarian Pharmaceutical Manufacturers (ABPhM) with the kind participation of the European Generic medicines Association (EGA) organise the international symposium: "Challenges for the National Drug Policy and Regulatory Practiceand Solutions for the Generic Medicines Industry"

The main representatives and discussed items were:

• “The Balance in the National Drug Policy and Optimization of Drugs
  Expenditure ”: D-r A. Shterev, MP, Chairman of Commission on Health
• “Challenges for the Generic Medicines Regulation in EU and the New
  Member States”: Greg Perry, Director General, EGA
• Challenges of the EU Accession for the National Regulatory Practice”:
  D-r E. Hristov, Executive Director, BDA
• "Experience of the Polish Pharmaceutical Industry with the EU
  Integration ”: Cezary Sledziewski, PZPPF
• “Challenges for the Bulgarian Generic Medicines Industry Regarding
  Drug Regulation in Bulgaria”: V. Afenliev, Actavis
  
• “National Measures to Promote Generic medicines ”: D-r B. Petrov,
  Director of Directorate “National Health Policy”, MoH
• “Challenges and Solutions for the Pricing and Reimbursement Systems”:
  D-r I. Bukarev, Executive Director of NHIF
• “Bulgarian Generic medicines Industry—on the doorstep to European
  Union”: D-r V. Kossev, Sopharma pharmaceuticals
• “Measures to Promote Generic Medicines in an Expanding EU”: EGA